Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
William Clark
Affiliation
Cancer Research UK Beatson Institute
ORCID
Career Start Year
1993
Papers
47
H Index
25
Expertise
CM4AI Collaborator
Trey Ideker (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36702176
Absent expansion of AXIN2+ hepatocytes and altered physiology in Axin2CreERT2 mice challenges the role of pericentral hepatocytes in homeostatic liver regeneration.
J Hepatol
2023
37580540
Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target.
Nat Metab
2023
36720858
Author Correction: Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features.
Nat Commun
2023
34628485
p53-mediated redox control promotes liver regeneration and maintains liver function in response to CCl<sub>4</sub>.
Cell Death Differ
2022
35477863
CXCR2 inhibition enables NASH-HCC immunotherapy.
Gut
2022
36477656
Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features.
Nat Commun
2022
33414552
The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer.
Nat Genet
2021
33627783
E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK-CBL-CIN85 axis.
Oncogene
2021
34435198
Specificity and off-target effects of AAV8-TBG viral vectors for the manipulation of hepatocellular gene expression in mice.
Biol Open
2021
34079124
NOTUM from Apc-mutant cells biases clonal competition to initiate cancer.
Nature
2021
33985973
SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer.
Cancer Res
2021
34314753
MICAL1 regulates actin cytoskeleton organization, directional cell migration and the growth of human breast cancer cells as orthotopic xenograft tumours.
Cancer Lett
2021
33431824
BRD4-mediated repression of p53 is a target for combination therapy in AML.
Nat Commun
2021
33397922
A RAC-GEF network critical for early intestinal tumourigenesis.
Nat Commun
2021
32156779
RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome.
Cancer Res
2020
32001510
Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence.
Genes Dev
2020
33033111
In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer.
Life Sci Alliance
2020
32200350
Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma.
Cancer Discov
2020
30760720
Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer.
Nat Commun
2019
31526760
Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis.
Cancer Cell
2019
30914643
Author Correction: Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer.
Nat Commun
2019
31032816
Identification of a Clinically Relevant Signature for Early Progression in KRAS-Driven Lung Adenocarcinoma.
Cancers (Basel)
2019
29719257
CSF1R<sup>+</sup> Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype.
Cell Rep
2018
29925636
The ERBB network facilitates KRAS-driven lung tumorigenesis.
Sci Transl Med
2018
30111642
TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence.
Sci Transl Med
2018
28525743
Bromodomain Protein BRD4 Is a Transcriptional Repressor of Autophagy and Lysosomal Function.
Mol Cell
2017
28351383
Diverse interventions that extend mouse lifespan suppress shared age-associated epigenetic changes at critical gene regulatory regions.
Genome Biol
2017
28238662
Coordination by Cdc42 of Actin, Contractility, and Adhesion for Melanoblast Movement in Mouse Skin.
Curr Biol
2017
29135975
Transcriptomic profiling of human breast and melanoma cells selected by migration through narrow constraints.
Sci Data
2017
27457071
Mapping H4K20me3 onto the chromatin landscape of senescent cells indicates a function in control of cell senescence and tumor suppression through preservation of genetic and epigenetic stability.
Genome Biol
2016
27824338
ROCK signalling induced gene expression changes in mouse pancreatic ductal adenocarcinoma cells.
Sci Data
2016
26299965
Mitotic Stress Is an Integral Part of the Oncogene-Induced Senescence Program that Promotes Multinucleation and Cell Cycle Arrest.
Cell Rep
2015
25315154
DNMT inhibitors reverse a specific signature of aberrant promoter DNA methylation and associated gene silencing in AML.
Genome Biol
2014
25512559
HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasia.
Genes Dev
2014
19595761
The C-terminus of Raf-1 acts as a 14-3-3-dependent activation switch.
Cell Signal
2009
15456874
c-Jun-deficient cells undergo premature senescence as a result of spontaneous DNA damage accumulation.
Mol Cell Biol
2004
12717415
v-Jun stimulates both cdk2 kinase activity and G1/S progression via transcriptional repression of p21 CIP1.
Oncogene
2003
12932827
Estrogen receptor activation function 2 (AF-2) is essential for hormone-dependent transactivation and cell transformation induced by a v-Jun DNA binding domain-estrogen receptor chimera.
Biochim Biophys Acta
2003
12226757
Cell transformation by v-Jun deactivates ERK MAP kinase signalling.
Oncogene
2002
10713176
v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
Mol Cell Biol
2000
10996792
Transient deactivation of ERK signalling is sufficient for stable entry into G0 in primary avian fibroblasts.
Curr Biol
2000
11127822
v-Jun sensitizes cells to apoptosis by a mechanism involving mitochondrial cytochrome C release.
Oncogene
2000
9837920
Analysis of the interaction between c-Jun and c-Jun N-terminal kinase in vivo.
J Biol Chem
1998
9427647
An oncogenic mutation uncouples the v-Jun oncoprotein from positive regulation by the SAPK/JNK pathway in vivo.
Curr Biol
1998
9101083
Transformation by v-Jun prevents cell cycle exit and promotes apoptosis in the absence of serum growth factors.
Cell Growth Differ
1997
8262050
Transcription activation by Myc and Max: flanking sequences target activation to a subset of CACGTG motifs in vivo.
EMBO J
1993
8510929
Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
Oncogene
1993
1 - 47 of 47
Column Actions
Search
Recommended Authors
Amanda R Wasylishen
The University of Texas MD Anderson Cancer Center
Career Start Year
2008
Number of shared co-authors
0
Eric Lau
Moffitt Cancer Center
Career Start Year
2006
Number of shared co-authors
1
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year
1998
Number of shared co-authors
0
Yaoqi Alan Wang
The University of Texas MD Anderson Cancer Center
Career Start Year
1997
Number of shared co-authors
0
Michael A White
University of Georgia
Career Start Year
1994
Number of shared co-authors
1
Celio Pouponnot
Institut Curie
Career Start Year
1993
Number of shared co-authors
1
John Alan Diehl
Case Western Reserve University School of Medicine
Career Start Year
1993
Number of shared co-authors
0
Andrei Goga
University of California San Francisco
Career Start Year
1993
Number of shared co-authors
0
Julien Sage
Department of Pediatrics Stanford University Stanford California USA.
Career Start Year
1993
Number of shared co-authors
1
Christoph Reinhard
Lilly Research Laboratories
Career Start Year
1992
Number of shared co-authors
0
James DeGregori
University of Colorado Anschutz Medical Campus
Career Start Year
1991
Number of shared co-authors
0
Linda Z Penn
University of Toronto
Career Start Year
1990
Number of shared co-authors
1
Eldad Zacksenhaus
University of Toronto
Career Start Year
1988
Number of shared co-authors
5
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year
1988
Number of shared co-authors
0
Kristian Helin
The Institute of Cancer Research
Career Start Year
1988
Number of shared co-authors
1
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year
1987
Number of shared co-authors
4
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year
1987
Number of shared co-authors
1
Rosalie C Sears
Oregon Health and Science University
Career Start Year
1987
Number of shared co-authors
1
Lori S Hart
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year
1987
Number of shared co-authors
0
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year
1987
Number of shared co-authors
3
Claudio Schneider
Laboratorio Nazionale-Consorzio Interuniversitario per le Biotecnologie
Career Start Year
1987
Number of shared co-authors
2
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Career Start Year
1984
Number of shared co-authors
2
Sylvain Meloche
Institute for Research in Immunology and Cancer
Career Start Year
1982
Number of shared co-authors
0
Ze'ev Ronai
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
1981
Number of shared co-authors
6
Michael C Ostrowski
Hollings Cancer Center, Medical University of South Carolina
Career Start Year
1979
Number of shared co-authors
0
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year
1979
Number of shared co-authors
1
Chi V Dang
Johns Hopkins University School of Medicine
Career Start Year
1978
Number of shared co-authors
0
Martine F Roussel
St. Jude Children's Research Hospital
Career Start Year
1977
Number of shared co-authors
1
Frank McCormick
Frederick National Laboratory for Cancer Research
Career Start Year
1975
Number of shared co-authors
1
Hartmut Land
University of Rochester Medical Center, Wilmot Cancer Institute
Career Start Year
1974
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Peter D Adams
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers
7
John J Cole
College of Medicine, University of Glasgow
Co-authored papers
5
Tony McBryan
The Beatson Institute
Co-authored papers
4
Neil A Robertson
Beatson Institute for Cancer Research and the University of Glasgow
Co-authored papers
4
Shelley L Berger
Penn Epigenetics Institute, Perelman School of Medicine
Co-authored papers
3
Claire Brock
Beatson Institute for Cancer Research and University of Glasgow
Co-authored papers
3
Jan Paul Medema
Oncode Institute
Co-authored papers
2
Amy M B McCorry
Queen's University Belfast
Co-authored papers
2
John Le Quesne
Beatson Cancer Research Institute, University of Glasgow
Co-authored papers
2
Mark Lawler
Queens University Belfast Belfast
Co-authored papers
2
Colin R Goding
Ludwig Institute for Cancer Research, University of Oxford
Co-authored papers
2
Fiona Ginty
GE Global Research Center
Co-authored papers
2
Tina Wang
Harvard University
Co-authored papers
1
Hans Clevers
Princess Maxima Center for Pediatric Oncology
Co-authored papers
1
Richard A Miller
University of Michigan School of Medicine ann arbor
Co-authored papers
1
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Co-authored papers
1
Martin E Gleave
University of British Columbia
Co-authored papers
1
Holly M Brown-Borg
University of North Dakota
Co-authored papers
1
Richard R Meehan
Institute of Genetics and Molecular Medicine, University of Edinburgh
Co-authored papers
1
Sandra Scharaw
Karolinska Institutet
Co-authored papers
1
Kari Alitalo
Wihuri Research Institute
Co-authored papers
1
Benjamin A Garcia
University of Pennsylvania
Co-authored papers
1
Ladan Fazli
University of British Columbia
Co-authored papers
1
Peter K Vogt
Co-authored papers
1
Ivan Dikic
Institute of Biochemistry II, Goethe University Frankfurt
Co-authored papers
1
John P Thomson
MRC Institute of Genetics and Cancer, University of Edinburgh
Co-authored papers
1
Steven W Criscione
Oncology R&D
Co-authored papers
1
Duncan Sproul
Institute of Genetics and Cancer, University of Edinburgh
Co-authored papers
1
James R Woodgett
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers
1
Ghulam Mohammad Rather
Islamic University of Science and Technology
Co-authored papers
1
1 - 30